CISPLATIN Drug Patent Profile

✉ Email this page to a colleague

Cisplatin is a drug marketed by Accord Hlthcare, Bedford, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hq Spclt Pharma, Norvium Bioscience, Pharmachemie Bv, Qilu, and Teva Pharms Usa. and is included in ten NDAs.

The generic ingredient in CISPLATIN is cisplatin. There are fourteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cisplatin profile page.

A generic version of CISPLATIN was approved as cisplatin by PHARMACHEMIE BV on May 16^th, 2000.

US Patents:	0
Applicants:	10
NDAs:	10
Finished Product Suppliers / Packagers:	10
Clinical Trials:	3,887
Drug Prices:	Drug price information for CISPLATIN
What excipients (inactive ingredients) are in CISPLATIN?	CISPLATIN excipients list
DailyMed Link:	CISPLATIN at DailyMed

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
EMD Serono	Phase 1
Fundación para el Progreso de la Oncología en Cantabria	Phase 2
Regeneron Pharmaceuticals	Phase 2

Drug Class	Platinum-based Drug

Antineoplastic Agents
Cross-Linking Reagents
Radiation-Sensitizing Agents

L01XA	Platinum compounds
L01X	OTHER ANTINEOPLASTIC AGENTS
L01	ANTINEOPLASTIC AGENTS
L	Antineoplastic and immunomodulating agents

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Accord Hlthcare	CISPLATIN	cisplatin	INJECTABLE;INJECTION	206774-001	Aug 18, 2015	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hq Spclt Pharma	CISPLATIN	cisplatin	INJECTABLE;INJECTION	018057-004	Nov 8, 1988	AP	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Fresenius Kabi Usa	CISPLATIN	cisplatin	INJECTABLE;INJECTION	074735-001	Jul 16, 1999	AP	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Pharms Usa	CISPLATIN	cisplatin	INJECTABLE;INJECTION	074814-001	May 16, 2000		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Hq Spclt Pharma	CISPLATIN	cisplatin	INJECTABLE;INJECTION	018057-004	Nov 8, 1988	⤷ Sign Up	⤷ Sign Up
Hq Spclt Pharma	CISPLATIN	cisplatin	INJECTABLE;INJECTION	018057-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Hq Spclt Pharma	CISPLATIN	cisplatin	INJECTABLE;INJECTION	018057-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Hq Spclt Pharma	CISPLATIN	cisplatin	INJECTABLE;INJECTION	018057-004	Nov 8, 1988	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

See the table below for patents covering CISPLATIN around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Cyprus	1159	PHARMACEUTICAL DORMULATIONS CONTAINING CISPLATINUM(11)DIAMMINEDICHLORIDE	⤷ Sign Up
New Zealand	189556	STABILISED AQUEOUS SOLUTIONS OF CISPLATIN	⤷ Sign Up
Norway	790313		⤷ Sign Up
Czechoslovakia	226002	METHOD OF STABILIZING AQUEOUS STERILE PLATINUM CIS-DIAMINE-DICHLORIDE SOLUTION	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration